INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo FML-NEO® Liquifilm Ophthalmic Suspension

SCHEDULING STATUS
Schedule 4

PROPRIETARY NAME
(and dosage form)

FML-NEO® Liquifilm Ophthalmic Suspension

COMPOSITION
Contained per mL:
Fluorometholone 1,0 mg
Neomycin sulfate (equivalent to 3,5 mg neomycin base) 5,0 mg

PHARMACOLOGICAL CLASSIFICATION
A. 15.2 Ophthalmic preparation with corticosteroids

Removed from this site: June 2018
Advised by: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2017